To the editor,In a recent review in the present journal, double carbapenem therapy against carbapenem-resistant Enterobacteriaceae (CRE) bloodstream infections was concluded to show lower mortality...
No takes yet. Share an insight, caveat, or question.
Bandali et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: